Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 70 articles:
HTML format
Text format



Single Articles


    November 2018
  1. THOMPSON JF, Scolyer RA, Lo SN
    ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas.
    Ann Surg Oncol. 2018 Nov 9. pii: 10.1245/s10434-018-7014.
    PubMed     Text format    


  2. YOUNG CJ
    ASO Author Reflections: Metastatic Melanoma to the Large Bowel.
    Ann Surg Oncol. 2018 Nov 7. pii: 10.1245/s10434-018-6972.
    PubMed     Text format    


    October 2018
  3. THOMPSON JF, Kroon HM
    ASO Author Reflections: Limited Surgery Plus Radiotherapy for Melanoma Patients with Cervical Node Metastases.
    Ann Surg Oncol. 2018 Oct 26. pii: 10.1245/s10434-018-6959.
    PubMed     Text format    


  4. FRIEDMAN EB, Dodds TJ, Lo S, Ferguson PM, et al
    Correlation Between Surgical and Histologic Margins in Melanoma Wide Excision Specimens.
    Ann Surg Oncol. 2018 Oct 16. pii: 10.1245/s10434-018-6858.
    PubMed     Text format     Abstract available


  5. ROBINSON AV, Peach H, Wade RG
    ASO Author Reflections: Hematological Biomarkers of Survival in Cutaneous Melanoma.
    Ann Surg Oncol. 2018 Oct 15. pii: 10.1245/s10434-018-6913.
    PubMed     Text format    


  6. EGGER ME, McMasters KM
    ASO Author Reflections: The Sentinel Lymph Node in Melanoma: Now More Important Than Ever.
    Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6855.
    PubMed     Text format    


  7. MURTHA TD, Han D
    ASO Author Reflections: Factors that Predict Performance of Sentinel Lymph Node Biopsy and the Association with Improved Survival for Melanoma Patients Who Have Nodal Staging.
    Ann Surg Oncol. 2018 Oct 9. pii: 10.1245/s10434-018-6841.
    PubMed     Text format    


  8. LOWE MC, Farley CR, Delman KA
    ASO Author Reflections: Optimizing the Outcomes for Patients: The Evolution of the Management of Regional Disease in Patients with Melanoma.
    Ann Surg Oncol. 2018 Oct 8. pii: 10.1245/s10434-018-6857.
    PubMed     Text format    


  9. PEREZ MC, Miura JT, Naqvi SMH, Kim Y, et al
    Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Melanoma: A Single-Institution Experience.
    Ann Surg Oncol. 2018 Oct 8. pii: 10.1245/s10434-018-6803.
    PubMed     Text format     Abstract available


  10. HIEKEN TJ, Kane JM 3rd, Wong SL
    The Role of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma.
    Ann Surg Oncol. 2018 Oct 3. pii: 10.1245/s10434-018-6812.
    PubMed     Text format     Abstract available


    September 2018
  11. AMIT M, Hanna EY
    ASO Author Reflections: Treatment Approaches to Sinonasal Mucosal Melanoma.
    Ann Surg Oncol. 2018 Sep 28. pii: 10.1245/s10434-018-6815.
    PubMed     Text format    


  12. LEE JS, Howard RA, Klueh MP, Englesbe MJ, et al
    The Impact of Education and Prescribing Guidelines on Opioid Prescribing for Breast and Melanoma Procedures.
    Ann Surg Oncol. 2018 Sep 20. pii: 10.1245/s10434-018-6772.
    PubMed     Text format     Abstract available


  13. LEONG SP
    The Intraoperative Portable Gamma Camera Is an Important Adjunct to the Gamma Probe in Identifying Melanoma Sentinel Lymph Nodes.
    Ann Surg Oncol. 2018 Sep 14. pii: 10.1245/s10434-018-6755.
    PubMed     Text format    


  14. FIELDS AC, Goldberg J, Senturk J, Saadat LV, et al
    Contemporary Surgical Management and Outcomes for Anal Melanoma: A National Cancer Database Analysis.
    Ann Surg Oncol. 2018 Sep 12. pii: 10.1245/s10434-018-6769.
    PubMed     Text format     Abstract available


  15. RAND JG, Faries MB
    Omitting Completion Dissection in Melanoma? Help is Available for Surgeons Coping Without Routine Dissection, But More Work is Needed.
    Ann Surg Oncol. 2018 Sep 12. pii: 10.1245/s10434-018-6744.
    PubMed     Text format    


    August 2018
  16. KROON HM, van der Bol WD, Tonks KT, Hong AM, et al
    Treatment of Clinically Positive Cervical Lymph Nodes by Limited Local Node Excision and Adjuvant Radiotherapy in Melanoma Patients with Major Comorbidities.
    Ann Surg Oncol. 2018 Aug 16. pii: 10.1245/s10434-018-6692.
    PubMed     Text format     Abstract available


  17. GERSHENWALD JE, Scolyer RA
    Correction to: Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
    Ann Surg Oncol. 2018 Aug 13. pii: 10.1245/s10434-018-6689.
    PubMed     Text format     Abstract available


  18. LEONG SP, Wu M, Lu Y, Torre DM, et al
    Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery.
    Ann Surg Oncol. 2018 Aug 13. pii: 10.1245/s10434-018-6685.
    PubMed     Text format     Abstract available


    July 2018
  19. WADE RG, Robinson AV, Lo MCI, Keeble C, et al
    Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study.
    Ann Surg Oncol. 2018 Jul 31. pii: 10.1245/s10434-018-6660.
    PubMed     Text format     Abstract available


  20. SINNAMON AJ, Song Y, Sharon CE, Yang YX, et al
    Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Ann Surg Oncol. 2018 Jul 24. pii: 10.1245/s10434-018-6647.
    PubMed     Text format     Abstract available


    June 2018
  21. MONCRIEFF MD, Gyorki D, Saw R, Spillane AJ, et al
    Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
    Ann Surg Oncol. 2018 Jun 26. pii: 10.1245/s10434-018-6612.
    PubMed     Text format     Abstract available


    May 2018
  22. MONCRIEFF MD, Gyorki D, Saw R, Spillane AJ, et al
    1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
    Ann Surg Oncol. 2018 May 30. pii: 10.1245/s10434-018-6470.
    PubMed     Text format     Abstract available


  23. GERSHENWALD JE, Scolyer RA
    Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
    Ann Surg Oncol. 2018 May 30. pii: 10.1245/s10434-018-6513.
    PubMed     Text format    


  24. KATSARELIAS D, Radbo E, Ben-Shabat I, Mattsson J, et al
    The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion.
    Ann Surg Oncol. 2018 May 15. pii: 10.1245/s10434-018-6459.
    PubMed     Text format     Abstract available


  25. BALCH CM
    Revolutionary Advances in Immunotherapy for Melanoma Are Coming into the Surgical Arena: Are We Ready?
    Ann Surg Oncol. 2018 May 11. pii: 10.1245/s10434-018-6516.
    PubMed     Text format    


  26. CUI C, Lian B, Zhou L, Song X, et al
    Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients.
    Ann Surg Oncol. 2018 May 10. pii: 10.1245/s10434-018-6503.
    PubMed     Text format     Abstract available


    April 2018
  27. PARK JS, Ng KS, Saw RPM, Thompson JF, et al
    Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience.
    Ann Surg Oncol. 2018 Apr 24. pii: 10.1245/s10434-018-6451.
    PubMed     Text format     Abstract available


  28. AMIT M, Tam S, Abdelmeguid AS, Kupferman ME, et al
    Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
    Ann Surg Oncol. 2018 Apr 6. pii: 10.1245/s10434-018-6465.
    PubMed     Text format     Abstract available


    March 2018
  29. EGGER ME, Xiao D, Hao H, Kimbrough CW, et al
    Unique Genes in Tumor-Positive Sentinel Lymph Nodes Associated with Nonsentinel Lymph Node Metastases in Melanoma.
    Ann Surg Oncol. 2018 Mar 1. pii: 10.1245/s10434-018-6377.
    PubMed     Text format     Abstract available


    February 2018
  30. ZABOR EC, Coit D, Gershenwald JE, McMasters KM, et al
    Variability in Predictions from Online Tools: A Demonstration Using Internet-Based Melanoma Predictors.
    Ann Surg Oncol. 2018 Feb 22. pii: 10.1245/s10434-018-6370.
    PubMed     Text format     Abstract available


  31. BELLO DM, Ariyan CE
    Adjuvant Therapy in the Treatment of Melanoma.
    Ann Surg Oncol. 2018 Feb 21. pii: 10.1245/s10434-018-6376.
    PubMed     Text format    


    January 2018
  32. MURTHA TD, Han G, Han D
    Predictors for Use of Sentinel Node Biopsy and the Association with Improved Survival in Melanoma Patients Who Have Nodal Staging.
    Ann Surg Oncol. 2018 Jan 24. pii: 10.1245/s10434-018-6348.
    PubMed     Text format     Abstract available


  33. TRINH BB, Chapman BC, Gleisner A, Kwak JJ, et al
    SPECT/CT Adds Distinct Lymph Node Basins and Influences Radiologic Findings and Surgical Approach for Sentinel Lymph Node Biopsy in Head and Neck Melanoma.
    Ann Surg Oncol. 2018 Jan 12. pii: 10.1245/s10434-017-6298.
    PubMed     Text format     Abstract available


  34. LO SN, Scolyer RA, Thompson JF
    Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors.
    Ann Surg Oncol. 2018 Jan 12. pii: 10.1245/s10434-017-6325.
    PubMed     Text format     Abstract available


  35. FARIES MB
    Completing the Dissection in Melanoma: Increasing Decision Precision.
    Ann Surg Oncol. 2018 Jan 4. pii: 10.1245/s10434-017-6330.
    PubMed     Text format    


  36. READ RL, Madronio CM, Cust AE, Goumas C, et al
    Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia.
    Ann Surg Oncol. 2018 Jan 3. pii: 10.1245/s10434-017-6319.
    PubMed     Text format     Abstract available


  37. SHIRAI K, Wong SL
    Melanoma Surveillance Strategies: Different Approaches to a Shared Goal.
    Ann Surg Oncol. 2018 Jan 2. pii: 10.1245/s10434-017-6321.
    PubMed     Text format    


    December 2017
  38. LI S, Sheng X, Si L, Cui C, et al
    Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.
    Ann Surg Oncol. 2017 Dec 21. pii: 10.1245/s10434-017-6256.
    PubMed     Text format     Abstract available


  39. WONG SL, Faries MB, Kennedy EB, Agarwala SS, et al
    Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Ann Surg Oncol. 2017 Dec 13. pii: 10.1245/s10434-017-6267.
    PubMed     Text format     Abstract available


    November 2017
  40. POSTLEWAIT LM, Farley CR, Seamens AM, Le N, et al
    Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6242.
    PubMed     Text format     Abstract available


  41. VOIT CA, van Akkooi ACJ, Catalano O, Eggermont AMM, et al
    Pre-SN Ultrasound-FNAC can be Sensitive for Lymph Node Metastases in Melanoma Patients if Performed with the Use of the Berlin Criteria.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6230.
    PubMed     Text format    


  42. CHAI C, Szabunio M, Cook C, Zager J, et al
    Pre-SN Ultrasound-FNAC for Lymph Node Metastases in Melanoma Patients: A Reply.
    Ann Surg Oncol. 2017 Nov 13. doi: 10.1245/s10434-017-6231.
    PubMed     Text format    


  43. MADU MF, van de Wiel B, van Akkooi ACJ
    Comment: Detailed Pathologic Examination of Completion Node Dissection Specimens and Outcome for Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6169.
    PubMed     Text format    


  44. CRAWFORD AB, Nessim C, Weaver J, van Walraven C, et al
    Wait Times for Melanoma Surgery: Is There an Association with Overall Survival?
    Ann Surg Oncol. 2017 Nov 3. doi: 10.1245/s10434-017-6146.
    PubMed     Text format     Abstract available


    October 2017
  45. HOLTKAMP LHJ, Wang S, Wilmott JS, Madore J, et al
    Reply to comment on: Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.
    Ann Surg Oncol. 2017 Oct 27. doi: 10.1245/s10434-017-6170.
    PubMed     Text format    


  46. ROSSI CR, Mocellin S, Campana LG, Borgognoni L, et al
    Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study.
    Ann Surg Oncol. 2017 Oct 24. doi: 10.1245/s10434-017-6143.
    PubMed     Text format     Abstract available


  47. FARIES MB, Mozzillo N, Kashani-Sabet M, Thompson JF, et al
    Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
    Ann Surg Oncol. 2017 Oct 10. doi: 10.1245/s10434-017-6072.
    PubMed     Text format     Abstract available


    August 2017
  48. KROON HM, Coventry BJ, Giles MH, Henderson MA, et al
    Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study.
    Ann Surg Oncol. 2017 Aug 10. doi: 10.1245/s10434-017-6046.
    PubMed     Text format     Abstract available


  49. POSTLEWAIT LM, Farley CR, Diller ML, Martin B, et al
    A Minimally Invasive Approach for Inguinal Lymphadenectomy in Melanoma and Genitourinary Malignancy: Long-Term Outcomes in an Attempted Randomized Control Trial.
    Ann Surg Oncol. 2017 Aug 2. doi: 10.1245/s10434-017-5971.
    PubMed     Text format     Abstract available


    May 2017
  50. VAREY AHR, Madronio CM, Cust AE, Goumas C, et al
    Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia.
    Ann Surg Oncol. 2017 May 25. doi: 10.1245/s10434-017-5890.
    PubMed     Text format     Abstract available


  51. KANG R, Wong SL
    Melanoma Surgery: Why Don't We Let the Guidelines Guide Practice?
    Ann Surg Oncol. 2017 May 22. doi: 10.1245/s10434-017-5891.
    PubMed     Text format    


  52. BEASLEY GM, Hu Y, Youngwirth L, Scheri RP, et al
    Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.
    Ann Surg Oncol. 2017 May 15. doi: 10.1245/s10434-017-5883.
    PubMed     Text format     Abstract available


    April 2017
  53. WRIGHT GP, Marsh JW, Varma MK, Doherty MG, et al
    Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
    Ann Surg Oncol. 2017;24:906-913.
    PubMed     Text format     Abstract available


    March 2017
  54. MORTON RL, Tran A, Vessey JY, Rowbotham N, et al
    Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications.
    Ann Surg Oncol. 2017 Mar 20. doi: 10.1245/s10434-017-5842.
    PubMed     Text format     Abstract available


  55. DAVIS JL, Langan RC, Panageas KS, Zheng J, et al
    Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.
    Ann Surg Oncol. 2017 Mar 16. doi: 10.1245/s10434-017-5836.
    PubMed     Text format     Abstract available


    February 2017
  56. JONES MS, Jones PC, Stern SL, Elashoff D, et al
    The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma.
    Ann Surg Oncol. 2017 Feb 21. doi: 10.1245/s10434-017-5775.
    PubMed     Text format     Abstract available


  57. MADU MF, Deken MM, van der Hage JA, Jozwiak K, et al
    Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.
    Ann Surg Oncol. 2017 Feb 10. doi: 10.1245/s10434-017-5803.
    PubMed     Text format     Abstract available


  58. DOEPKER MP, Yamamoto M, Applebaum MA, Patel NU, et al
    Comparison of Single-Photon Emission Computed Tomography-Computed Tomography (SPECT/CT) and Conventional Planar Lymphoscintigraphy for Sentinel Node Localization in Patients with Cutaneous Malignancies.
    Ann Surg Oncol. 2017;24:355-361.
    PubMed     Text format     Abstract available


  59. FAUT M, Heidema RM, Hoekstra HJ, van Ginkel RJ, et al
    Morbidity After Inguinal Lymph Node Dissections: It Is Time for a Change.
    Ann Surg Oncol. 2017;24:330-339.
    PubMed     Text format     Abstract available


  60. LATCHANA N, Del Campo SE, Grignol VP, Clark JR, et al
    Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
    Ann Surg Oncol. 2017;24:347-354.
    PubMed     Text format     Abstract available


    January 2017
  61. PARK TS, Phan GQ, Yang JC, Kammula U, et al
    Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.
    Ann Surg Oncol. 2017 Jan 31. doi: 10.1245/s10434-017-5768.
    PubMed     Text format     Abstract available


  62. CROOKES TR, Scolyer RA, Lo S, Drummond M, et al
    Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.
    Ann Surg Oncol. 2017 Jan 27. doi: 10.1245/s10434-016-5723.
    PubMed     Text format     Abstract available


  63. BHUTIANI N, Egger ME, McMasters KM
    Optimizing Follow-up Assessment of Patients with Cutaneous Melanoma.
    Ann Surg Oncol. 2017 Jan 24. doi: 10.1245/s10434-017-5771.
    PubMed     Text format    


  64. STEWART CL, Gleisner A, Kwak J, Chapman B, et al
    Implications of Sentinel Lymph Node Drainage to Multiple Basins in Head and Neck Melanoma.
    Ann Surg Oncol. 2017 Jan 5. doi: 10.1245/s10434-016-5744.
    PubMed     Text format     Abstract available


    November 2016
  65. KARAKOUSIS G, Gimotty PA, Bartlett EK, Sim MS, et al
    Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  66. LEE AY, Droppelmann N, Panageas KS, Zhou Q, et al
    Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  67. HAO H, Xiao D, Pan J, Qu J, et al
    Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  68. FAUT M, Wevers KP, van Ginkel RJ, Diercks GF, et al
    Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  69. KLEMEN ND, Feingold PL, Goff SL, Hughes MS, et al
    Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  70. ENGELHARDT KE, Wayne JD, Bilimoria KY
    Editorial: Should We Abandon TNM Staging in Favor of Gene Profiles in Node-Positive Melanoma?
    Ann Surg Oncol. 2016.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: